IMC Chicago
ADMA icon

IMC Chicago’s ADMA Biologics ADMA Stock Holding History

IMC Chicago’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$848K Buy
94,100
+3,500
+4% +$55.2K ﹤0.01% 3446
2025
Q4 		$1.65M Buy
90,600
+31,700
+54% +$534K ﹤0.01% 2575
2025
Q3 		$863K Buy
58,900
+21,400
+57% +$367K ﹤0.01% 2819
2025
Q2 		$683K Buy
37,500
+13,800
+58% +$281K ﹤0.01% 2697
2025
Q1 		$470K Buy
+23,700
New +$410K ﹤0.01% 2693

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

IMC Chicago's ADMA Position: Q1 2026 in Review

IMC Chicago increased its ADMA Biologics (ADMA) stake by 194% in Q1 2026, buying an estimated $646K and bringing the position to 62,075 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

IMC Chicago first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • IMC Chicago held 62,075 shares of ADMA Biologics worth $559K as of Q1 2026.
  • IMC Chicago bought 40,964 ADMA Biologics shares in Q1 2026, an estimated $646K.
  • ADMA Biologics made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3924 holding.
  • IMC Chicago first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.